Home
Categories
EXPLORE
True Crime
Comedy
Business
Society & Culture
Health & Fitness
Sports
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Podjoint Logo
US
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/fe/e2/6c/fee26c7e-7fe5-039d-3683-af49e519fda5/mza_6371497309821078762.jpg/600x600bb.jpg
Cell Mates
Multiply Labs
3 episodes
4 months ago
What tasks are humanoids uniquely good at and what does that mean for the future of work? In Episode 2 of Cell Mates, we invite Tony Yang, Director of North American Markets from Unitree Robotics to discuss the future of humanoid robots and how robots can fundamentally change the future. We explore in particular what this means for the biomanufacturing industry. Highlights include: Where do humanoids fit in pharma?What makes robotic adoption difficult (yet inevitable)?What could a future fill...
Show more...
Life Sciences
Technology,
Business,
Entrepreneurship,
Science
RSS
All content for Cell Mates is the property of Multiply Labs and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
What tasks are humanoids uniquely good at and what does that mean for the future of work? In Episode 2 of Cell Mates, we invite Tony Yang, Director of North American Markets from Unitree Robotics to discuss the future of humanoid robots and how robots can fundamentally change the future. We explore in particular what this means for the biomanufacturing industry. Highlights include: Where do humanoids fit in pharma?What makes robotic adoption difficult (yet inevitable)?What could a future fill...
Show more...
Life Sciences
Technology,
Business,
Entrepreneurship,
Science
Episodes (3/3)
Cell Mates
Cell Mates Podcast Ep. 2 | Humanoid Robots and the Future of Biomanufacturing
What tasks are humanoids uniquely good at and what does that mean for the future of work? In Episode 2 of Cell Mates, we invite Tony Yang, Director of North American Markets from Unitree Robotics to discuss the future of humanoid robots and how robots can fundamentally change the future. We explore in particular what this means for the biomanufacturing industry. Highlights include: Where do humanoids fit in pharma?What makes robotic adoption difficult (yet inevitable)?What could a future fill...
Show more...
4 months ago
24 minutes

Cell Mates
Cell Mates Podcast Ep. 1 | Where Science & Engineering Collide in Pharma Automation
What happens when scientists and engineers collaborate to tackle the biggest challenges in pharma manufacturing? In this debut episode, Multiply Labs CEO Frederico Parietti, Ph.D., sits down with Sanket Acharya, Ph.D., Senior Director of Corporate Development at GenScript, to explore the critical intersection of science and automation. Key topics we cover: ⚙️ What engineers often misunderstand about science 🔬 What scientists often get wrong about engineering 🤝 How cross-disciplinary collabor...
Show more...
8 months ago
21 minutes

Cell Mates
Cell Mates Podcast Ep. 1 Preview | Where Science & Engineering Collide in Pharma Automation
What’s the biggest difference between how scientists and engineers think? 🤔 What happens when you put scientists and engineers in the same room to brainstorm solutions to some of pharma’s biggest challenges? Multiply Labs explores these very questions and more in their NEW podcast: Cell Mates, the podcast that is building the future of pharma automation, one conversation at a time! 🎧You won’t want to miss this…
Show more...
8 months ago
1 minute

Cell Mates
What tasks are humanoids uniquely good at and what does that mean for the future of work? In Episode 2 of Cell Mates, we invite Tony Yang, Director of North American Markets from Unitree Robotics to discuss the future of humanoid robots and how robots can fundamentally change the future. We explore in particular what this means for the biomanufacturing industry. Highlights include: Where do humanoids fit in pharma?What makes robotic adoption difficult (yet inevitable)?What could a future fill...